New in @CCR_AACR : we can read the physical state of the HPV genome from a tube of blood — and it's prognostic of recurrence and survival across HPV+ cancers. 🧵
World leaders discuss the future of cancer diagnostics and monitoring at the First Annual Liquid Biopsy Summit organized by Dr Daniel Faden
#AHNS#AHNS2026
DPhil student Michael Bryan has been awarded the prestigious British Neuro-Oncology Society (BNOS) Young investigator Award, for his work on using AI and computational biology to design better personalised cancer vaccines for people with glioblastoma
Find out more on our website
Great trip to Kyoto for the AACR-JCA meeting. Wonderful to see old friends and make new ones. Thank you to @AACR and outgoing AACR president @lillian_siu for the invitation to speak on our work advancing liquid biopsy - and the late night yakitori, chicken hearts, liver and all.
A whole genome sequencing assay named HPV-DeepSeek sniffs out signs of residual disease after surgery in patients with #HPV+ head and neck cancer, and detects recurrence earlier than digital PCR and standard clinical criteria. @FadenLab@BIDharvardOHNSscim.ag/3S52VLF
Big day for our lab! New paper using our HPV-DeepSeek assay, an ultrasensitive HPV WGS-based liquid biopsy for MRD detection in HPV+ head & neck cancer, is out today in @ScienceTM 🧵
🔗 science.org/doi/10.1126/scit…
Huge thanks to our co-first authors Shun Hirayama, Yana Al-Inaya, @Michael_E_Bryan, @dipondas30 and @alanyelg. And to our clinical and scientific teams @MassEyeAndEar, @MassGeneralNews, Broad Institute, Broad Clincal Labs. This is what collaborative science looks like